To further explore how EZH2 is involved in glioma pathogenesis, we performed GSEA between tissues with different EZH2 expression levels and found that EZH2 expression was associated with essential signalling pathways, including cell cycle, DNA replication, mismatch repair, p53 signalling and pyrimidine metabolism. This evidence concerns the gene TP53 and central nervous system cancer.